Payment overview · 2025
General Payments
$13.85
1 reported records · 1 companies
Healthcare provider profile · identity verified
Patti Beard Wheeler, MD
Allopathic & Osteopathic Physicians|Family Medicine · HIGHLANDS, NC · NPI 1265411169
Verified facts
What the public records show
CMS Open Payments records show Patti Beard Wheeler, MD received $13.85 in general payments during 2025 across 1 reported records.
Dexcom, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $13.85 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $13.85 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $13.85 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 442 | 131 |
| Levothyroxine Sodium | Levothyroxine Sodium | 416 | 121 |
| Amlodipine Besylate | Amlodipine Besylate | 391 | 116 |
| Lisinopril | Lisinopril | 377 | 95 |
| Pantoprazole Sodium | Pantoprazole Sodium | 377 | 105 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 373 | 112 |
| Hydrochlorothiazide | Hydrochlorothiazide | 252 | 72 |
| Tamsulosin Hcl | Tamsulosin Hcl | 239 | 76 |
| Escitalopram Oxalate | Escitalopram Oxalate | 231 | 59 |
| Metoprolol Succinate | Metoprolol Succinate | 230 | 68 |
| Gabapentin | Gabapentin | 216 | 62 |
| Omeprazole | Omeprazole | 213 | 65 |
| Potassium Chloride | Potassium Chloride | 206 | 45 |
| Quetiapine Fumarate | Quetiapine Fumarate | 205 | 38 |
| Eliquis | Apixaban | 204 | 43 |
| Alprazolam | Alprazolam | 195 | 38 |
| Trazodone Hcl | Trazodone Hcl | 179 | 46 |
| Synthroid | Levothyroxine Sodium | 172 | 36 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 170 | 56 |
| Tramadol Hcl | Tramadol Hcl | 165 | 40 |
| Telmisartan | Telmisartan | 161 | 48 |
| Xarelto | Rivaroxaban | 154 | 26 |
| Metformin Hcl | Metformin Hcl | 150 | 45 |
| Allopurinol | Allopurinol | 147 | 42 |
| Duloxetine Hcl | Duloxetine Hcl | 137 | 28 |
| Lorazepam | Lorazepam | 131 | 33 |
| Clonazepam | Clonazepam | 127 | 21 |
| Jardiance | Empagliflozin | 125 | 28 |
| Losartan Potassium | Losartan Potassium | 125 | 45 |
| Ozempic | Semaglutide | 123 | 20 |
| Zolpidem Tartrate | Zolpidem Tartrate | 123 | 32 |
| Furosemide | Furosemide | 114 | 34 |
| Metoprolol Tartrate | Metoprolol Tartrate | 110 | 31 |
| Pregabalin | Pregabalin | 110 | 38 |
| Simvastatin | Simvastatin | 105 | 25 |
| Clopidogrel | Clopidogrel Bisulfate | 103 | 28 |
| Atenolol | Atenolol | 101 | 31 |
| Methylprednisolone | Methylprednisolone | 94 | 75 |
| Spironolactone | Spironolactone | 94 | 26 |
| Dutasteride | Dutasteride | 92 | 28 |
| Tizanidine Hcl | Tizanidine Hcl | 89 | 33 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 88 | 20 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 85 | 26 |
| Montelukast Sodium | Montelukast Sodium | 84 | 22 |
| Azithromycin | Azithromycin | 81 | 68 |
| Famotidine | Famotidine | 73 | 24 |
| Celecoxib | Celecoxib | 72 | 19 |
| Diclofenac Sodium | Diclofenac Sodium | 71 | 31 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 69 | 17 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 68 | 17 |
| Carvedilol | Carvedilol | 67 | 22 |
| Estradiol | Estradiol | 61 | 20 |
| Paroxetine Hcl | Paroxetine Hcl | 61 | 16 |
| Finasteride | Finasteride | 58 | 16 |
| Oxycodone Hcl | Oxycodone Hcl | 58 | 15 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 56 | 15 |
| Donepezil Hcl | Donepezil Hcl | 53 | 19 |
| Pravastatin Sodium | Pravastatin Sodium | 53 | 16 |
| Fluticasone Propionate | Fluticasone Propionate | 52 | 19 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 51 | 13 |
| Myrbetriq | Mirabegron | 48 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 48 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 48 | suppressed |
| Prednisone | Prednisone | 47 | 19 |
| Mirtazapine | Mirtazapine | 45 | 15 |
| Levofloxacin | Levofloxacin | 44 | 39 |
| Citalopram Hbr | Citalopram Hydrobromide | 43 | 13 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 43 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 42 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 42 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 41 | suppressed |
| Entresto | Sacubitril/Valsartan | 40 | suppressed |
| Fentanyl | Fentanyl | 40 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 40 | 14 |
| Symbicort | Budesonide/Formoterol Fumarate | 40 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 39 | suppressed |
| Sucralfate | Sucralfate | 39 | 12 |
| Meloxicam | Meloxicam | 38 | 16 |
| Primidone | Primidone | 38 | suppressed |
| Torsemide | Torsemide | 38 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 38 | 19 |
| Memantine Hcl | Memantine Hcl | 37 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 37 | suppressed |
| Rybelsus | Semaglutide | 36 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 36 | 13 |
| Amitriptyline Hcl | Amitriptyline Hcl | 35 | suppressed |
| Baclofen | Baclofen | 35 | suppressed |
| Ezetimibe | Ezetimibe | 34 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 33 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 33 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 33 | suppressed |
| Acyclovir | Acyclovir | 32 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 32 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 32 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 31 | 28 |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 31 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 30 | suppressed |
| Temazepam | Temazepam | 30 | suppressed |
| Ondansetron Odt | Ondansetron | 29 | 16 |
| Ropinirole Hcl | Ropinirole Hcl | 29 | suppressed |
| Lamotrigine | Lamotrigine | 28 | suppressed |
| Cefadroxil | Cefadroxil | 27 | 18 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 27 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 27 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 27 | 12 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 26 | 12 |
| Colesevelam Hcl | Colesevelam Hcl | 25 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 25 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 25 | suppressed |
| Mounjaro | Tirzepatide | 25 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 25 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 24 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 24 | suppressed |
| Diazepam | Diazepam | 24 | suppressed |
| Irbesartan | Irbesartan | 23 | suppressed |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 23 | suppressed |
| Bumetanide | Bumetanide | 22 | suppressed |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 22 | suppressed |
| Hydrocortisone | Hydrocortisone | 22 | 13 |
| Benazepril Hcl | Benazepril Hcl | 21 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 21 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 21 | 16 |
| Propranolol Hcl | Propranolol Hcl | 21 | suppressed |
| Repatha Sureclick | Evolocumab | 21 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 21 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 20 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 20 | suppressed |
| Carisoprodol | Carisoprodol | 20 | suppressed |
| Effexor Xr | Venlafaxine Hcl | 20 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 20 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 20 | suppressed |
| Minoxidil | Minoxidil | 20 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 20 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 20 | suppressed |
| Colchicine | Colchicine | 19 | 11 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 19 | suppressed |
| Nicotrol Ns | Nicotine | 19 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 19 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 19 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 18 | suppressed |
| Fenofibrate | Fenofibrate | 18 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 18 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 17 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 17 | suppressed |
| Creon | Lipase/Protease/Amylase | 17 | suppressed |
| Glimepiride | Glimepiride | 17 | suppressed |
| Jantoven | Warfarin Sodium | 17 | suppressed |
| Januvia | Sitagliptin Phosphate | 17 | suppressed |
| Lovastatin | Lovastatin | 17 | suppressed |
| Nabumetone | Nabumetone | 17 | suppressed |
| Trulicity | Dulaglutide | 17 | suppressed |
| Clonidine | Clonidine | 16 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 16 | suppressed |
| Novolog Flexpen | Insulin Aspart | 16 | suppressed |
| Tymlos | Abaloparatide | 16 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 15 | suppressed |
| Glipizide Er | Glipizide | 15 | suppressed |
| Nadolol | Nadolol | 15 | suppressed |
| Topiramate | Topiramate | 15 | suppressed |
| Valsartan | Valsartan | 15 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 14 | suppressed |
| Premarin | Estrogens, Conjugated | 14 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 14 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 13 | suppressed |
| Bupropion Xl | Bupropion Hcl | 13 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 13 | 13 |
| Digoxin | Digoxin | 13 | suppressed |
| Metronidazole | Metronidazole | 13 | suppressed |
| Nitroglycerin | Nitroglycerin | 13 | 11 |
| Terazosin Hcl | Terazosin Hcl | 13 | suppressed |
| Clarithromycin | Clarithromycin | 12 | suppressed |
| Fluconazole | Fluconazole | 12 | suppressed |
| Indapamide | Indapamide | 12 | suppressed |
| Levetiracetam | Levetiracetam | 12 | suppressed |
| Methadone Hcl | Methadone Hcl | 12 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 12 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 12 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 12 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 11 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 11 | suppressed |
| Mesalamine | Mesalamine | 11 | suppressed |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 11 | suppressed |
| Repatha Syringe | Evolocumab | 11 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $13.85 · 1 records | Dexcom, Inc. | Dexcom G6 Transmitter | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error